(SDDI) is a Philippine Joint Venture company with an equal partnership with Safeguard Biosystems, formed to provide a Molecular Microbiology diagnostic laboratory delivering rapid detection and identification to primarily infectious disease and COVID-19 for the Philippine healthcare. Safeguard Biosystems is an international molecular diagnostics company that has developed a low cost, high-throughput, molecular diagnostic technology platform. The system enables rapid identification by DNA of the most prevalent bacterial and fungal pathogens directly from blood. Clinical samples can be tested from matrices such as whole blood, urine, peritoneal fluid, and swabs. As a reflex test for positive samples, the system provides an extensive menu of tests to determine the presence of resistance genes. The system’s proprietary multiplexed PCR can deliver reliable and accurate results within hours directly from whole blood without the need for culture (current “gold standard” tests are less reliable and take at least 1-3 days). The system enables physicians to rapidly diagnose the pathogens that cause a patient’s infection and prescribe appropriate antimicrobial therapy for singular or poly-microbial infections. Such earlier diagnoses can reduce morbidity and mortality as well as offer significant cost benefits for healthcare providers. Early and appropriate use of antibiotics is an essential step in addressing the growing incidence of global antimicrobial resistance. Our Mission
To make molecular testing fast, simple and cost effective that every patient will be tested for every infection, lessening misdiagnoses and significantly limiting the spread of infectious disease in the Philippines
Our Vision
The trusted molecular diagnostic company - empowering lives through Accessibility, Accuracy, and Affordability.
